The primary goal of our company is the continuous improvement of the nucleotides, nucleic acids, and their derivatives that we supply, as well as the enhancement of internal processes to meet all customer requirements. Our objective is to ensure the highest quality and the highest level of safety for the nucleotides, nucleic acids, and their derivatives that we produce.
Based on the latest technologies, high qualifications, and the experience of our associates, ExploRNA Therapeutics Sp. z o.o. is committed to:
The implementation of the quality policy is ensured by the commitment of all associates at ExploRNA. Intermediate goals supporting the realization of this policy include:
We are committed to meeting all applicable requirements, including legal, administrative, and other relevant regulations, as well as continuously improving the effectiveness of our Quality Management System, in compliance with the PN-EN ISO 9001:2015 standard.
The quality policy is known and adhered to by all employees at all levels of the organization.
Marek Baranowski
Director of Research and Quality Development
View our ISO 9001:2015 Certification: (en) ISO 9001 2015